markets

Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now

Yahoo Finance

Qualcomm and Amazon ink deal for custom data center chips

Yahoo Finance

United Natural Foods, Inc. Q4 2026 Earnings Call Summary

Yahoo Finance

Gamehaus Holdings Inc. Q4 2026 Earnings Call Summary

Yahoo Finance

SpaceX’s stock could jump 43% — if the company is able to accomplish this engineering feat

Failing to successfully scale the Starship rocket would make SpaceX’s plans a lot more difficult.

MarketWatch

T-Pain buys private jet — just a few years after borrowing cash to get Burger King. Break your bad spending habits now

Yahoo Finance

401(k) savers are setting records. How to catch up if you're behind.

Yahoo Finance

Fidelity says 50-year-olds need $551,280 saved for retirement — the average 401(k) balance is just $215,700

Yahoo Finance

These software stocks are in a prime spot to benefit from a rapidly shifting AI landscape

Adobe tops a list of software companies ranked by cash generation, while sector heavyweights Microsoft and Oracle are at the bottom.

MarketWatch

SpaceX trades 11% above its $135 IPO price as analysts target $280 — but one investor warns valuation is 'beyond silly'

Yahoo Finance

$1.5 million in your 401(k)? Here’s what your RMD taxes will look like — and the very best trick to lower them

Yahoo Finance

Strong Results Lifted Garrett Motion (GTX) in Q2

Yahoo Finance

Bombardier’s stock drops as the U.S.-Canada trade war intensifies. Here’s what Trump may target next.

The trade battle — featuring steep import taxes and possible bans — could escalate further as soon as today.

MarketWatch

Evaluating Bullish Potential in Regeneron Pharmaceuticals (REGN) Stock

Yahoo Finance

The Kroger Co. (KR) Shares Weighed by Inflation Pressure and Slowing Sales

Yahoo Finance

Intel’s stock is rising as the company looks primed to boost prices even more

The chip maker is reportedly set to further lift prices on its PC chips as costs rise across the supply chain.

MarketWatch

Oracle’s stock gets a boost as the OpenAI ecosystem comes back into favor

“It looks like OpenAI is turning things around,” and that’s seen as good news for Oracle, which has a lot riding on the ChatGPT creator’s success.

MarketWatch

Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff

Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.

MarketWatch